Terrapin Asset Management’s European Biotech Acquisition Corp. Units EBACU Stock Holding History

Terrapin Asset Management’s Portfolio EBACU Stock Details EBACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-600	Closed	-$6.04K	–	222
2022 Q4	$6.04K	Buy	+600	New	+$6.01K	0.01%	188

Terrapin Asset Management's EBACU Position: Q1 2023 in Review

Terrapin Asset Management sold out of European Biotech Acquisition Corp. Units (EBACU) in Q1 2023, closing a stake of 600 shares — an estimated $6.04K sold.

Terrapin Asset Management first reported a position in EBACU in Q4 2022 and held it in 1 quarter. The position peaked at $6.04K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBACU as of Q1 2023.

Terrapin Asset Management reported no remaining European Biotech Acquisition Corp. Units position as of Q1 2023 after selling out during the quarter.
Terrapin Asset Management sold 600 European Biotech Acquisition Corp. Units shares in Q1 2023, an estimated $6.04K.
Terrapin Asset Management first reported a position in European Biotech Acquisition Corp. Units in Q4 2022 and held it in 1 quarter.
Terrapin Asset Management's European Biotech Acquisition Corp. Units position peaked at $6.04K in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Units as of Q1 2023.

Based on Terrapin Asset Management's 13F filing for Q1 2023, filed 12 May 2023.